A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. Issue 8 (August 2022)
- Record Type:
- Journal Article
- Title:
- A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. Issue 8 (August 2022)
- Main Title:
- A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz
- Authors:
- Hassan Bulbul, Md. Rakibul
Uddin Chowdhury, Mohammad Nizam
Naima, Taslima Anjum
Sami, Saad Ahmed
Imtiaj, Md. Shakil
Huda, Nazmul
Uddin, Md. Giash - Abstract:
- Abstract: Terminalia chebula Retz, commonly known as 'Haritaki/Myrobalan, ' has been utilised as a traditional medicine for a long time. It has been extensively exercised in various indigenous medicine practices like Unani, Tibb, Ayurveda, and Siddha to remedy human ailments such as bleeding, carminative, dysentery, liver tonic, digestive, antidiarrheal, analgesic, anthelmintic, antibacterial and helpful in skin disorders. Studies on the pharmacological effects of T. chebula and its phytoconstituents documented between January, 1996 and December, 2021 were explored using various electronic databases. During the time mentioned above, several laboratory approaches revealed the biological properties of T. chebula, including antioxidative, antiproliferative, anti-microbial, proapoptotic, anti-diabetic, anti-ageing, hepatoprotective, anti-inflammatory, and antiepileptic. It is also beneficial in glucose and lipid metabolism and prevents atherogenesis and endothelial dysfunction. Different parts of T. chebula such as fruits, seeds, galls, barks extracted with various solvent systems (aqueous, ethanol, methanol, chloroform, ethyl-acetate) revealed major bioactive compounds like chebulic acid, chebulinic acid, and chebulaginic acid, which in turn proved to have valuable pharmacological properties through broad scientific investigations. There is a common link between chebulagic acid and chebulanin with its antioxidant property, antiaging activity, antiinflammatory, antidiabeticAbstract: Terminalia chebula Retz, commonly known as 'Haritaki/Myrobalan, ' has been utilised as a traditional medicine for a long time. It has been extensively exercised in various indigenous medicine practices like Unani, Tibb, Ayurveda, and Siddha to remedy human ailments such as bleeding, carminative, dysentery, liver tonic, digestive, antidiarrheal, analgesic, anthelmintic, antibacterial and helpful in skin disorders. Studies on the pharmacological effects of T. chebula and its phytoconstituents documented between January, 1996 and December, 2021 were explored using various electronic databases. During the time mentioned above, several laboratory approaches revealed the biological properties of T. chebula, including antioxidative, antiproliferative, anti-microbial, proapoptotic, anti-diabetic, anti-ageing, hepatoprotective, anti-inflammatory, and antiepileptic. It is also beneficial in glucose and lipid metabolism and prevents atherogenesis and endothelial dysfunction. Different parts of T. chebula such as fruits, seeds, galls, barks extracted with various solvent systems (aqueous, ethanol, methanol, chloroform, ethyl-acetate) revealed major bioactive compounds like chebulic acid, chebulinic acid, and chebulaginic acid, which in turn proved to have valuable pharmacological properties through broad scientific investigations. There is a common link between chebulagic acid and chebulanin with its antioxidant property, antiaging activity, antiinflammatory, antidiabetic activity, and cardioprotective activity. The actions may be through neutralizing the free radicals responsible for producing tissue damage alongside interconnecting many other diseases. The current review summarises the scientifically documented literature on pharmacological potentials and chemical compositions of T. chebula, which is expected to investigate further studies on this subject. Abstract : Terminalia chebula ; Myrobalan; Haritaki; Phytochemistry; Pharmacological activities. … (more)
- Is Part Of:
- Heliyon. Volume 8:Issue 8(2022)
- Journal:
- Heliyon
- Issue:
- Volume 8:Issue 8(2022)
- Issue Display:
- Volume 8, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 8
- Issue:
- 8
- Issue Sort Value:
- 2022-0008-0008-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08
- Subjects:
- Terminalia chebula -- Myrobalan -- Haritaki -- Phytochemistry -- Pharmacological activities
Research -- Periodicals
Medical sciences -- Periodicals
Natural history -- Periodicals
Social sciences -- Periodicals
Earth sciences -- Periodicals
Physical sciences -- Periodicals
507.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/24058440/ ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.heliyon.2022.e10220 ↗
- Languages:
- English
- ISSNs:
- 2405-8440
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23307.xml